# Therapeutic Goods Administration (TGA)

Type: Company

Source: Legal & RegTech Intelligence Brief — https://getlegalbrief.com/entity/therapeutic-goods-administration-tga
Canonical HTML page: https://getlegalbrief.com/entity/therapeutic-goods-administration-tga

## Timeline

- **2026**: Implementation — New pricing structures and stricter clinical criteria for reimbursement are expected to take effect.
- **2026-02-27**: Subsidy Cut Announcement — Government announces plans to slash subsidies for SCS devices based on findings that they 'don't work' for many patients.
- **2025**: Regulatory Review — The TGA and Department of Health initiate a formal review into the clinical efficacy of spinal cord stimulators.
- **2024**: Rising Adverse Events — Increased reporting of 'failed back surgery syndrome' and device-related injuries in Australian hospitals.

## Recent coverage (1 stories)

### Australian Regulators to Slash Subsidies for High-Risk Spinal Implants
2026-02-27 09:16:11 · Sentiment: Negative · Impact: 7/10 · Sources: 3

The Australian government is moving to drastically reduce subsidies for spinal cord stimulators following evidence of severe patient injuries and a lack of clinical efficacy. This regulatory pivot marks a major shift in medical device reimbursement, prioritizing long-term safety over industry-led innovation claims.
Full story: https://getlegalbrief.com/story/australia-spinal-implant-subsidy-cuts-regulation

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getlegalbrief.com/guides/methodology for the full editorial methodology.